Clinical response to FGFR inhibitors in patients with FGFR2-amplified advanced gastric cancer: two case reports - Top-Institutions - MDSpire

Clinical response to FGFR inhibitors in patients with FGFR2-amplified advanced gastric cancer: two case reports

  • By

  • Jing-Jing Li

  • Yu- Qian

  • Hui-Ting Xu

  • Yan-Li Nie

  • July 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital Cancer Center

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #3

    Yonsei University College of Medicine
    Yonsei University College of Medicine

    Seoul, South Korea

    Key Differentiators

    • Oncology

  • #4

    Songdang Institute for Cancer Research
    Songdang Institute for Cancer Research

    Seoul, South Korea

    Key Differentiators

    • Oncology

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

Clinical response to FGFR inhibitors in patients with FGFR2-amplified advanced gastric cancer: two case reports

  • by Jing-Jing Li, Yu- Qian, Hui-Ting Xu, Yan-Li Nie

  • July 7, 2026

Related Content

Improving CT-CBCT deformable image registration for cervical cancer adaptive radiotherapy using a deep learning approach

Reconstruction of large truncal defects post-malignant tumor excision using triple rhomboid flaps

Molecular mechanisms and targeted interventions for embolic risk in cardiac myxoma: from molecular heterogeneity to clinical translation